PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmaceutical Nanotechnology Research Laboratory, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana, India.\', \'Department of Pharmacology, National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana, India.\', \'Pharmaceutical Nanotechnology Research Laboratory, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana, India. Electronic address: neelesh@niperhyd.ac.in.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0024-3205(20)31088-210.1016/j.lfs.2020.118336
?:doi
?:hasPublicationType
?:journal
  • Life sciences
is ?:pmid of
?:pmid
?:pmid
  • 32846164
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.071
?:rankingScore_hIndex
  • 145
?:title
  • COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32846164>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32846164>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all